French insurtech Alan has raised €480M led by Prosus at a €5.5bn valuation, just months after its last round. The Paris company is betting that AI-driven prevention can reshape health insurance. Alan, the French health insurance company, has raised €48…
The partnership will fund EU AI hardware and data centres, and launch aiUSX, a yield asset that puts companies’ idle AI cash to work as infrastructure lending. Building sovereign AI in Europe takes chips, and chips take capital. TensorX and Solstice sa…
The Berlin startup points cameras at production lines, converts the footage into live data, and says it has lifted output at Bosch and ABB plants. Now it wants the US. Berlin startup that films what happens on a factory floor and turns it into live pro…
Tombot, a Los Angeles-area company that makes a robotic dog for people who cannot keep a real one, has closed a $7m Series A3 financing round to move its flagship product from development into manufacturing. The company said on June 24 that the round d…
Runpod has raised $100M and reached a $1bn valuation, a tenfold jump in under two years. The cloud startup rents out AI computing power, and it says it turned down buyout offers worth more than $500M. The great AI compute crunch is minting a new kind o…
Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab of light-cured glue. For a severed nerve, the standard repair has barel…
Morgan Stanley has doubled its forecast for China humanoid robot shipments again, to 50,000 this year. The bank says the machines are moving from stage demos to real factories, shops and restaurants. China’s robots are leaving the showroom and reaching…
xLight, a US-backed startup chaired by former Intel chief Pat Gelsinger, is raising $350m to build an xLight EUV light source that could loosen ASML’s grip on chipmaking. Days earlier, a Dutch rival took aim at Nvidia. Deep-tech chips are hot again. Th…
Cerebras nearly doubled its revenue and guided 2026 sales above Wall Street’s estimates. Its stock still fell about 10%. The reason was a margin squeeze, caused not by a shortage of chips but by a shortage of buildings. Cerebras just learned the price …
Two of Apple’s biggest Chinese suppliers are racing to Hong Kong in the same week. Luxshare wants about $3bn, Lingyi just banked $1.1bn. Both are using the cash to pivot from smartphone parts to AI hardware and humanoid robots. The companies that build…